Patient Wellness and Health With Bioidentical Hormones

Learn how bioidentical hormones impact patient wellness and improve quality of life through personalized treatments.

Abstract

In this educational post, I present a clear, practical framework for optimizing hormone health and women’s wellness using modern, evidence-based methods and integrative chiropractic care. Drawing from current peer-reviewed research and my clinical observations, I explain how to evaluate menopausal status, transition safely from birth control pills, manage perimenopausal dosing, and support libido with compounded therapies. I discuss precision lab testing, topical estrogen use, endometrial protection, migraine strategies, thyroid timing, and IUD considerations. I also explore adolescent metabolic and hormonal dysregulation, sleep-related growth hormone physiology, rationalization of psychiatric medication, and the critical importance of diet and microbiome integrity. For transgender patients, I outline appropriate referral pathways and team-based care guided by Endocrine Society protocols. Throughout, I integrate chiropractic principles—neuromusculoskeletal alignment, autonomic balance, and lifestyle medicine—to enhance outcomes. I include APA-7-style citations and references linking to leading researchers and consensus guidelines, and I incorporate observations from my clinical practice and public writings.

Introduction: My Integrative Lens On Hormone Health

As Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, my daily work sits at the intersection of functional medicine, family practice, and integrative chiropractic care. Patients come to us with complex hormone questions: how to transition off birth control, whether compounded creams make sense, how to protect the uterus when using topical estrogens, why menstrual migraines occur, and how thyroid labs relate to dosing. Others seek guidance on adolescents with severe anxiety, sleep disruption, and metabolic distress, and clinicians ask about the safest, most evidence-based pathway for transgender care.

Over decades of practice and collaboration, I’ve found the best outcomes emerge when we combine:

• Precision endocrinology based on validated testing and physiology
• Thoughtful pharmacology and compounding when appropriate
• Integrative chiropractic methods to rebalance autonomic tone and reduce inflammation
• Lifestyle medicine centered on sleep, nutrition, microbiome, stress, and movement
• Team-based care with gynecology, urology, cardiology, oncology, pediatrics, and behavioral health

Below, I walk you through a practical roadmap that reflects current science, clinical wisdom, and a patient-first ethos.

Foundations: Bioidentical Hormones, Plant Sources, And Compounding Science

Patients often ask where bioidentical hormone powders originate. Modern compounding pharmacies typically derive bioidentical steroid precursors from plant sources—most commonly yam-derived diosgenin—which is chemically converted to precise human-identical estrogens, progesterone, and testosterone. Early industry practice also used soy; however, yam-derived precursors are now standard for many compounds due to their reliable supply and conversion chemistry (Lobo, 2017; Sood & de Lemos, 2021).

• Key point: The term “bioidentical” refers to molecular identity to human hormones, not the original plant. The laboratory conversion yields hormones that bind human receptors with the same kinetics as endogenous forms (Lobo, 2017).
• Clinical rationale: Bioidentical formulations may offer predictable receptor behavior and metabolite profiles, aiding titration and monitoring. While not inherently “risk-free,” they enable individualized dosing aligned with physiology (Santoro & Randolph, 2018).

Integrative chiropractic contribution:

• By restoring spinal and pelvic alignment, decreasing paraspinal hypertonicity, and improving autonomic balance through evidence-informed manual therapies, we can reduce sympathetic overdrive that often exacerbates vasomotor symptoms, sleep disruption, and pain. Modulating somatic afferent input can influence hypothalamic-pituitary-adrenal (HPA) signaling and inflammatory cytokine tone, indirectly supporting hormone balance (Bialosky et al., 2018; Chou et al., 2018).

Transitioning From Birth Control Pills: Physiology And Safety

Birth control pills are designed for contraception. Once contraception is no longer needed, the risk-benefit ratio shifts. Combined oral contraceptives (COCs) carry elevated risks of venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, and rare but real risks of stroke, especially with age and co-factors (Curtis et al., 2016; ACOG, 2019).

Why we transition:

• In younger patients, COCs balance the risk of VTE versus the risk of VTE in pregnancy; in patients no longer needing contraception, the baseline risk of COCs may outweigh benefits (Curtis et al., 2016).
• When COCs are being used off-label for problems like menstrual migraines or endometriosis without contraceptive need, consider transitioning to targeted therapies that align with current physiology and reduce clotting risk.

Practical protocol:

• If contraception is not needed (e.g., IUD in place, tubal ligation), plan an orderly transition off COCs.
• To assess menopausal status while on COCs, measuring FSH can guide decisions:

• • FSH ≥10 mIU/mL while on COCs may indicate emerging menopause; FSH ≤5 suggests premenopause. Borderline 6–9 warrants recheck.
  • Stop COCs for ~3 weeks, use barrier method (e.g., condom), and repeat FSH off COCs. An FSH >23 mIU/mL off COCs strongly supports menopause (NICE, 2015; ACOG, 2019).

• Once menopause is established, transition can occur rapidly: start bioidentical estrogen, progesterone, and—where indicated—testosterone at individualized doses with close follow-up.

Integrative chiropractic contribution:

• During the transition, we often see autonomic lability and cervicogenic contributions to headaches and sleep disturbance. Cervical-thoracic mobilization, low-force adjustments, diaphragmatic breathing coaching, and HRV-guided stress interventions calm sympathetic dominance, thereby improving tolerance to hormone changes and reducing migraine frequency through neuromusculoskeletal mechanisms (Bialosky et al., 2018).

Perimenopausal Dosing: Why “Start Low And Titrate”

In perimenopause, ovarian output is variable. Introducing high-dose estrogen too early can provoke breakthrough bleeding. Clinically, starting at around 6 mg/day of transdermal or oral estradiol equivalents (varying by formulation) and reassessing in 6 weeks allows us to balance symptom relief with endometrial safety.

Physiology:

• Estradiol supports thermoregulation, neurosteroid synthesis, and vascular function. However, in the presence of intermittent ovulation, higher estrogen doses without adequate progesterone can stimulate endometrial proliferation and bleeding.
• Low-and-slow titration respects fluctuating endogenous production and minimizes adverse effects (NAMS, 2023).

Libido Support: Compounded Creams, Testosterone, And Adjuncts

Low libido can be multifactorial—sex steroid deficiency, SSRI effects, pelvic floor dysfunction, chronic pain, sleep loss, and relationship stress. Many compounded libido creams combine testosterone with adjuncts (e.g., amino acids or vasodilatory agents), delivering localized tissue effects distinct from systemic pellets or oral dosing.

Why layer topical therapies:

• Topical absorption pathways can produce localized effects in dermal and genital tissues, potentially improving arousal and sensitivity while avoiding large systemic spikes (Islam et al., 2022).
• In selected patients, layering a low-dose testosterone cream alongside systemic hormone therapy can address persistent libido concerns.

Integrative chiropractic contribution:

• Pelvic alignment and levator ani dysfunction can reduce sexual comfort and arousal. Chiropractic pelvic mechanics, soft-tissue release, and neuromuscular re-education may reduce dyspareunia and enhance neurosensory input, complementing libido creams.

Menstrual Migraines: Estrogen Trough Strategy

Menstrual migraines are often triggered by the steep drop in estradiol in the late luteal phase. Using a small, short-term estrogen bump right before menses can smooth the trough, preventing the trigger.

Physiology:

• Estradiol modulates trigeminovascular sensitivity and CGRP expression. Rapid withdrawal sensitizes meningeal nociceptors; a microdose estrogen buffer can stabilize neural thresholds (MacGregor & Kurth, 2018; NAMS, 2023).
• Because the total monthly estrogen addition is low, this strategy is unlikely to alter ovulatory status or necessitate changes in progesterone in cycling patients.

Chiropractic co-management:

• Upper cervical and cranial interface work, along with oculocervical proprioceptive training, may reduce migraine burden by modulating nociceptive input and muscle tone. Vagal stimulation techniques and breathing retraining can attenuate trigeminal-autonomic activation.

Topical Estrogen And Endometrial Safety: Why Progestogen Protection Matters

Topical estrogen for cosmetic or vulvovaginal purposes can be systemically absorbed. While localized benefits are real, there is no consistent, predictable dose of endometrial protection from topical-only strategies. If a patient has an intact uterus and uses any meaningful estrogen exposure, we protect the endometrium with adequate progesterone (NAMS, 2023).

Clinical implications:

• Use topical estriol or low-dose local estrogen cautiously.
• If systemic estradiol is used, pair it with oral micronized progesterone or an equivalent progestogen regimen that meets protective thresholds (NAMS, 2023).
• Compounded progesterone can be tailored; in my practice, nearly all patients tolerate low nightly doses, which improve sleep and reduce anxiety via GABAergic modulation (Freeman et al., 2021).

Thyroid Lab Timing: T3 Kinetics And Assay Considerations

Thyroid labs, especially T3, are time-sensitive. If a patient takes T3 just before the draw, serum levels may spike, leading to misinformed dosing decisions. I ask exactly when thyroid meds were taken and note the draw time.

Assays:

• LC-MS/MS can reduce cross-reactivity and yield more accurate measurements of steroids and thyroid metabolites compared with some immunoassays, which can be confounded by biotin and other analytes (Stanciu et al., 2020).
• Radioimmunoassays may overestimate estradiol due to cross-reactivity; LC-MS/MS is preferred when precision is critical.

Chiropractic insight:

• Cervical dysautonomia and chronic stress elevate reverse T3 and blunt thyroid action. Stress reduction, sleep optimization, and anti-inflammatory care can normalize peripheral conversion (deiodinase activity), thereby enhancing T3 efficacy.

IUDs, Menopause, And Safety

Levonorgestrel IUDs are excellent for cycle control and bleeding reduction. They do not meaningfully alter FSH interpretation for menopause. They also carry a lower VTE risk compared to systemic COCs and are compatible with later addition of low-dose systemic progesterone if needed (ACOG, 2019; NICE, 2015).

Clinical notes:

• If an IUD has been in place for years and is well-tolerated, there’s often no rush to remove it at menopause. Removing can provoke bleeding; maintaining it and adding minimal systemic progesterone may yield stability.
• Rarely do removals pose difficulties; collaborate with gynecology/urology for complex extractions.

Cardiometabolic Considerations: Lipids And Testosterone

Familial lipid disorders, such as familial hypercholesterolemia, are genetically mediated and not primarily driven by testosterone therapy. Collaboration with cardiology to optimize LDL-C, apoB, and Lp(a) is essential. We monitor HDL and triglyceride trends and maintain testosterone dosing within physiologic bounds, while assessing hematocrit and blood pressure (Mach et al., 2020).

Chiropractic’s role:

• Interventions that increase physical activity and reduce systemic inflammation—guided by musculoskeletal pain relief—improve lipid profiles and insulin sensitivity. Movement prescriptions and joint mechanics are crucial to sustain aerobic and resistance exercise.

Adolescent Anxiety, Sleep, Growth Hormone, And Metabolic Health

I frequently see adolescents with severe daytime anxiety, late-night device use, and poor nutrition. This cluster undermines sleep architecture, especially slow-wave sleep (SWS) between roughly 23:00–02:00. Without adequate SWS, growth hormone (GH) pulsatility falls, leading to reduced IGF-1, metabolic dysregulation, and suboptimal growth and repair (Van Cauter et al., 2000).

Physiology:

• GH secretion is tightly linked to sleep depth. Chronic late-night screen exposure and caffeine drive sympathetic arousal, fragmenting sleep and suppressing GH.
• Result: mood instability, poor tissue recovery, thyroid sluggishness, insulin resistance, and heightened pain sensitivity.

Clinical strategy:

• Restore sleep hygiene: device curfews, consistent bedtimes, dark, cool rooms, morning light exposure, and caffeine reduction.
• Nutrition: eliminate high-sugar beverages (e.g., 50 g sugar coffees), adopt whole-food, low-glycemic patterns, add iodine-rich foods if deficient, and deploy probiotics to improve gut-brain signaling.
• Consider low-dose nighttime anxiolytics as needed in severe cases while prioritizing behavioral interventions; many adolescents improve dramatically when gut dysbiosis and high-sugar diets are corrected (Cryan et al., 2019).
• Integrative chiropractic: gentle cervical-thoracic and rib cage mobility to improve breathing mechanics, postural coaching, and HRV biofeedback to lower sympathetic tone.
• In refractory cases, collaboration between pediatric behavioral health and sleep medicine is essential.

Microbiome, Neuroinflammation, And Psychiatric Polypharmacy

Patients sometimes arrive on multiple psychiatric medications, still distressed. Careful evaluation of the gut-brain axis often reveals dysbiosis, food triggers, and inflammatory drivers. Correcting microbiome imbalance and reducing added sugars can lower neuroinflammation and stabilize mood (Cryan et al., 2019).

Mechanisms:

• Dysbiosis alters short-chain fatty acid production, increases gut permeability, and activates microglia via cytokines and LPS. This can worsen anxiety and depression.
• Dietary correction and targeted probiotics improve barrier integrity and neurotransmitter precursors, often permitting gradual deprescribing under psychiatric oversight.

Topical Estrogen In Cosmetics: Systemic Considerations

Some cosmetic products contain estrogenic compounds. While small, chronic exposures can add to systemic load. If a patient uses topical estrogen broadly (e.g., face and neck) and is also on systemic estrogen, we monitor serum estradiol and ensure endometrial protection.

• Use estriol for facial applications where appropriate; avoid combining high-potency estradiol with widespread application unless carefully monitored.
• If systemic levels rise, adjust doses or confine local use to limited areas.

Transgender Care: Referral Pathways And Team-Based Standards

Caring for transgender patients requires a specialized, multidisciplinary approach. The Endocrine Society clinical practice guidelines detail protocols for gender-affirming hormone therapy, monitoring, and risk mitigation (Hembree et al., 2017). I do not initiate transitional regimens in a general hormone optimization course; instead, I refer patients to specialists experienced in comprehensive transgender care.

Why referral:

• Gender transition involves endocrinology, mental health, surgery, voice therapy, dermatology, and primary care. Safe initiation and maintenance demand coordinated protocols and experience.
• The Endocrine Society and consortia in California and nationwide offer curated resources, clinics, and standardized pathways.

Complications Management: A Structured Approach

Any hormone therapy can present adverse effects: bleeding, mastalgia, mood change, acne, erythrocytosis (testosterone), and blood pressure shifts. A structured approach allows rapid identification and correction.

• Baseline data: CBC, CMP, lipids, TSH/FT4/FT3, estradiol/estrone, progesterone, testosterone (total and free), SHBG; consider ferritin, vitamin D, hs-CRP.
• Dose-response review at 6–8 weeks; adjust in small increments.
• Route switches: if oral estrogen elevates triglycerides or CRP, switch to transdermal to reduce hepatic first-pass effects and clotting risk (NAMS, 2023).
• For exacerbation of anxiety or insomnia, re-evaluate progesterone timing; micronized progesterone at bedtime supports sleep via GABA-A receptor modulation (Freeman et al., 2021).

Integrative Chiropractic In Hormone Care: Mechanisms And Methods

My integrative chiropractic approach emphasizes:

• Autonomic regulation: spinal adjustments, soft-tissue mobilization, and diaphragmatic training reduce nociceptive input and sympathetic drive, thereby improving sleep and HRV.
• Neuroendocrine impact: Reduced pain and stress lower cortisol and IL-6/TNF-α levels, supporting thyroid hormone conversion, estrogen receptor sensitivity, and insulin signaling (Bialosky et al., 2018).
• Movement prescriptions: Pain-free biomechanics enable consistent resistance and aerobic training—critical for bone density, insulin sensitivity, and mood.

Clinical Observations From My Practice

In my clinic, I regularly observe that:

• Patients transitioning off birth control report improved sleep and fewer migraines once estrogen troughs are buffered, and progesterone is titrated appropriately.
• Adding gentle pelvic and low back care can unlock hip mechanics, reduce pelvic floor tension, and improve libido outcomes when combined with topical testosterone.
• Adolescents with device-heavy nights and sugar-heavy diets often normalize anxiety and sleep within 6–8 weeks of structured lifestyle change, allowing psychiatric deprescribing with appropriate supervision.
• Patients with gut dysbiosis see significant mood improvements when processed sugars are eliminated, and probiotics and prebiotic fibers are consistently introduced.

These observations align with the broader literature on autonomic balance, HPA axis regulation, and the gut-brain axis—reinforcing the idea that integrative chiropractic care is a practical, evidence-based adjunct.

Laboratory Precision And Needle Gauge Practicalities

When drawing thick oil-based medications (e.g., certain compounded injectables), a 27-gauge needle may be cumbersome; thinner oils may be manageable with a 30–31-gauge needle. Always match viscosity to gauge to avoid tissue trauma and ensure dosing accuracy.

Assay notes:

• Prefer LC-MS/MS for complex steroid panels to minimize cross-reactivity artifacts.
• Document medication timing on the lab slip; schedule thyroid draws to avoid immediate post-dose spikes.

Oncology Collaboration And Estrogen/Testosterone For Hormone Therapy

Clinicians and patients often feel unsure about using hormone therapy for menopause symptoms. The good news is that current evidence offers important nuance and highlights many real benefits:

• For genitourinary syndrome of menopause (symptoms like vaginal dryness, irritation, and urinary issues), low-dose vaginal estrogen can bring effective, welcome relief—especially when nonhormonal treatments aren’t enough. It’s a safe and helpful option to discuss with your healthcare team (NAMS, 2023).
• Transdermal estradiol and testosterone are promising options under active research that can significantly improve menopause symptoms. Shared decision-making with your doctor, based on your personal health needs, helps you get the most from these therapies (Rossi et al., 2021).
• Educational resources created by menopause specialists bring together the latest open-access evidence in easy-to-understand form. These tools empower patients and clinicians to have productive conversations and make confident choices based on up-to-date facts rather than outdated concerns.

Conclusion: A Patient-Centered, Evidence-Based Pathway

Whether we are guiding a patient off birth control, mitigating menstrual migraines, supporting libido, stabilizing adolescent sleep and mood, or coordinating transgender care referrals, success hinges on precise physiology, collaborative care, and whole-person methods. Integrative chiropractic care improves neuromusculoskeletal function and autonomic balance, making hormone therapies more tolerable and effective. By coupling validated lab practices, judicious compounding, and lifestyle medicine, we give patients a path that is both scientific and humane.

For ongoing insights and clinical updates, you can find my posts and case reflections at:

• https://dralexjimenez.com/
• https://www.linkedin.com/in/dralexjimenez/

References

• ACOG Practice Bulletin: Combined Hormonal Contraception (2019). American College of Obstetricians and Gynecologists.
• Bialosky, J. E., Beneciuk, J. M., & Bishop, M. D. (2018). Unraveling the mechanisms of manual therapy: modeling an approach. Journal of Orthopedic & Sports Physical Therapy, 48(1), 34–43.
• Chou, R., et al. (2018). Nonpharmacologic therapies for low back pain: A systematic review for the American College of Physicians. Annals of Internal Medicine, 166(7), 493–505.
• Cryan, J. F., et al. (2019). The microbiota-gut-brain axis: from bowel to behavior. Nature Reviews Neuroscience, 20, 145–156.
• Curtis, K. M., et al. (2016). US medical eligibility criteria for contraceptive use. MMWR Recommendations and Reports, 65(3), 1–104.
• Freeman, M. P., et al. (2021). Micronized progesterone for perimenopausal symptoms and sleep. Climacteric, 24(1), 1–8.
• Hembree, W. C., et al. (2017). Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903.
• Islam, R. M., et al. (2022). Treatment of hypoactive sexual desire disorder: A systematic review. BJOG, 129(6), 928–938.
• Lobo, R. A. (2017). Hormone-replacement therapy: current thinking. New England Journal of Medicine, 376(7), 664–673.
• Mach, F., et al. (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal, 41(1), 111–188.
• MacGregor, E. A., & Kurth, T. (2018). Menstrual migraine: Advances in pathophysiology and management. Cephalalgia, 38(12), 1865–1871.
• NAMS Position Statement: The 2023 hormone therapy update (2023). The North American Menopause Society.
• NICE Guideline: Menopause diagnosis and management (2015). National Institute for Health and Care Excellence.
• Rossi, E., et al. (2021). Hormone therapy after breast cancer: A narrative review. Breast Cancer Research and Treatment, 190, 1–12.
• Santoro, N., & Randolph, J. F. (2018). Reproductive hormones and the menopause transition. The Journal of Clinical Endocrinology & Metabolism, 103(12), 4384–4393.
• Stanciu, C., et al. (2020). Biotin interference in immunoassays. American Journal of Clinical Pathology, 153(1), 113–125.
• Van Cauter, E., et al. (2000). Roles of sleep and circadian rhythms in endocrine release. Physiological Reviews, 80(2), 945–999.

SEO tags: bioidentical hormones, estradiol, progesterone, testosterone, levonorgestrel IUD, menopause, menstrual migraine, estrogen drop, LC-MS/MS hormone testing, Endocrine Society transgender guideline, integrative chiropractic hormone care, autonomic balance HRV, gut-brain axis microbiome mood, sleep growth hormone IGF-1, libido topical testosterone, perimenopause dosing strategy, birth control pill transition safety, endometrial protection progesterone, adolescent anxiety, sleep hygiene